Guardant Health, Inc. - Common Stock (GH)

CUSIP: 40131M109

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
123,850,680
Total 13F shares
122,493,323
Share change
-1,734,989
Total reported value
$7,653,044,062
Put/Call ratio
122%
Price per share
$62.48
Number of holders
388
Value change
-$62,866,800
Number of buys
199
Number of sells
171

Quarterly Holders Quick Answers

What is CUSIP 40131M109?
CUSIP 40131M109 identifies GH - Guardant Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q3 2025

As of 30 Sep 2025, Guardant Health, Inc. - Common Stock (GH) was held by 388 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,493,323 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., BAILLIE GIFFORD & CO, Invesco Ltd., Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, Deep Track Capital, LP, EVENTIDE ASSET MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 388 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.